RANINasdaqPharmaceutical PreparationsFiscal year ends December 31
Rani Therapeutics Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.65+0.01 (+1.51%)
Close on Oct 19, 2026
- Market cap
- $121.72M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$1.63MFY2025, +28.7% a year since FY2020